Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis

被引:38
|
作者
Kumar, Amit [1 ,2 ]
Vaish, Manisha [1 ]
Ratan, Rajiv R. [1 ,2 ,3 ]
机构
[1] Burke Med Res Inst, White Plains, NY 10065 USA
[2] Cornell Univ, Brain & Mind Res Inst, Weill Med Coll, White Plains, NY 10605 USA
[3] Cornell Univ, Dept Neurol, Weill Med Coll, White Plains, NY 10605 USA
基金
美国国家卫生研究院;
关键词
GENE-EXPRESSION CHANGES; QUINOLINIC ACID MODEL; MUTANT HUNTINGTIN; MOUSE MODEL; MEDIATED TRANSCRIPTION; STRIATAL NEURONS; BINDING PROTEIN; POLYGLUTAMINE; SP1; INHIBITION;
D O I
10.1016/j.drudis.2014.03.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Huntington's disease (HD) is a signature polyglutamine disorder. An enduring theory of HD pathogenesis has involved dysregulation of transcription. Indeed, transcriptional regulatory proteins can be modulated to overcome cardinal features of HD-modeled mice, and efforts to move these into human studies are ongoing. Here, we discuss a unifying hypothesis emerging from these studies, which is that HD represents the pathological disruption of evolutionarily conserved adaptive gene programs to counteract oxidative stress, mitochondrial dysfunction and accumulation of misfolded proteins. Transcriptional dyshomeostasis of adaptive genes is further exacerbated by repression of genes involved in normal synaptic activity or growth factor signaling.
引用
收藏
页码:956 / 962
页数:7
相关论文
共 50 条
  • [1] Transcriptional dysregulation in Huntington's disease
    Duce, J
    Hartog, C
    Elliston, L
    Neal, JW
    Nicholson, LFB
    Jones, AL
    [J]. BASAL GANGLIA VII, 2002, 52 : 491 - 499
  • [2] Transcriptional dysregulation in Huntington's disease
    Cha, JHJ
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (09) : 387 - 392
  • [3] Transcriptional dysregulation in Huntington's disease.
    Duce, J
    Hartog, C
    Elliston, L
    Bates, G
    Jones, L
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 545 - 545
  • [4] Mechanisms of transcriptional dysregulation in Huntington's disease
    Luthi-Carter, R
    Cha, JHJ
    [J]. CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 165 - 177
  • [5] The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease
    Buckley, Noel J.
    Johnson, Rory
    Zuccato, Chiara
    Bithell, Angela
    Cattaneo, Elena
    [J]. NEUROBIOLOGY OF DISEASE, 2010, 39 (01) : 28 - 39
  • [6] Transcriptional dysregulation in Huntington's disease: The role of histone deacetylases
    Sharma, Sorabh
    Taliyan, Rajeev
    [J]. PHARMACOLOGICAL RESEARCH, 2015, 100 : 157 - 169
  • [7] Transcriptional dysregulation in Huntington's disease involve ubiquitylation of histones
    Cha, Jang-Ho
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S12 - S12
  • [8] Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease
    Sbodio, Juan I.
    Snyder, Solomon H.
    Paul, Bindu D.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (31) : 8843 - 8848
  • [9] Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington's disease
    McConoughey, Stephen J.
    Basso, Manuela
    Niatsetskaya, Zoya V.
    Sleiman, Soma F.
    Smimova, Natalia A.
    Langley, Brett C.
    Mahishi, Lata
    Cooper, Arthur J. L.
    Antonyak, Marc A.
    Cerione, Rick A.
    Li, Bo
    Starkov, Anatoly
    Chaturvedi, Rajnish Kumar
    Beal, M. Flint
    Coppola, Giovanni
    Geschwind, Daniel H.
    Ryu, Hoon
    Xia, Li
    Iisma, Siiri E.
    Pallos, Judit
    Pasternack, Ralf
    Hils, Martin
    Fan, Jing
    Raymond, Lynn A.
    Marsh, J. Lawrence
    Thompson, Leslie M.
    Ratan, Rajiv R.
    [J]. EMBO MOLECULAR MEDICINE, 2010, 2 (09) : 349 - 370
  • [10] A Systematic Review of Transcriptional Dysregulation in Huntington's Disease Studied by RNA Sequencing
    Malla, Bimala
    Guo, Xuanzong
    Senger, Gokce
    Chasapopoulou, Zoi
    Yildirim, Ferah
    [J]. FRONTIERS IN GENETICS, 2021, 12